Skip to main content
Edwards Lifesciences Logo

The latest news on transcatheter mitral and tricuspid therapies

TMTT Hero

Discover how EVOQUE TTVR is transforming care for patients with tricuspid regurgitation

TMTT Today issue #14 – image
TMTT Today issue #14 – Nov 2025

  • From pivotal trial to real-world impact: uncover the  latest TTVR evidence from TRISCEND II and both EU  and US registries
  • Explore four clinical cases where EVOQUE TTVR  made the difference by eliminating TR* across a  wide range of anatomies

*TR elimination to mild or less

Get Edwards updates

Be the first to hear about the latest Edwards news, evidence and future events by joining our mailing list today.

Medical device for professional use

Medical device for professional use

For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).

PP--EU-5247 v8.0